Yahoo Web Search

    • Moderna Surges to Record High as Vaccine Maker Added to S&P 500

      TheStreet.com· 2 weeks ago

      Moderna Inc. shares surged to a fresh record high Friday after the vaccine maker was tipped to enter the S&P 500 benchmark next week. A 93% efficacy rate was also noted 14 days after the first of the vaccine's two dose regiment, Moderna said.